小兒驚厥治療藥物市場：依給藥（液體、固體）、給藥（口服、腸外）-全球預測 2023-2030

全球兒科驚厥藥物市場預計將大幅成長，預計2030年將達到5.9124億美元，年複合成長率為6.42%，2023年將達到3.8175億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球兒科驚厥藥物市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.小兒驚厥治療藥物全球市場規模及預測為何？

2.在預測期內，COVID-19對全球小兒驚厥治療藥物市場的阻礙因素與影響有哪些？

3.在預測期內，全球小兒驚厥治療藥物市場需要投資哪些產品/細分市場/用途/領域？

4.小兒驚厥治療藥物全球市場的競爭策略為何？

5. 全球兒科驚厥治療藥物市場的技術趨勢和法律規範是什麼？

6.全球小兒驚厥治療藥物市場主要廠商的市佔率為何？

7. 哪些型態和策略性舉措被認為適合進入小兒驚厥藥物全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 中樞神經系統 (CNS)感染疾病的盛行率
    • 兒童癲癇藥物的普及不斷增加
    • 意識提升，以減少未確診病例的數量
  • 抑制因素
    • 嬰兒痙攣症治療費用高且缺乏正確診斷
  • 機會
    • 擴大嬰兒痙攣症治療的科學進步
    • 增加廣泛的研發活動
  • 任務
    • 藥品核准的嚴格法規
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 小兒驚厥治療藥物市場：按給藥

• 介紹
• 液體
• 堅硬的

第7章 小兒驚厥治療藥物市場：依給藥途徑

• 介紹
• 口服
• 家長

第8章 北美和南美小兒癲癇治療藥物市場

• 介紹
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太地區小兒驚厥治療藥物市場

• 介紹
• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲小兒驚厥治療藥物市場

• 介紹
• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可證和定價

The Global Infantile Spasms Therapeutics Market is forecasted to grow significantly, with a projected USD 381.75 million in 2023 at a CAGR of 6.42% and expected to reach a staggering USD 591.24 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Infantile Spasms Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Infantile Spasms Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Dosage, market is studied across Liquid and Solid. The Liquid is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Oral and Parental. The Parental is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Infantile Spasms Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Infantile Spasms Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Infantile Spasms Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Infantile Spasms Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Infantile Spasms Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Infantile Spasms Therapeutics Market?

6. What is the market share of the leading vendors in the Global Infantile Spasms Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Infantile Spasms Therapeutics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Infantile Spasms Therapeutics Market, by Dosage, 2022 vs 2030
• 4.3. Infantile Spasms Therapeutics Market, by Route of Administration, 2022 vs 2030
• 4.4. Infantile Spasms Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of central nervous system (CNS) infection
    • 5.1.1.2. Rising penetration rate of infantile spasm drugs
    • 5.1.1.3. Awareness by government and private organizations to decrease the number of undiagnosed cases
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of treatment and lack of proper diagnosis of infantile spasm
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding scientific advancements in the treatment for infantile spasms
    • 5.1.3.2. Increasing extensive research and development activities
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations for drug approval
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Infantile Spasms Therapeutics Market, by Dosage

• 6.1. Introduction
• 6.2. Liquid
• 6.3. Solid

7. Infantile Spasms Therapeutics Market, by Route of Administration

• 7.1. Introduction
• 7.2. Oral
• 7.3. Parental

8. Americas Infantile Spasms Therapeutics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Infantile Spasms Therapeutics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Infantile Spasms Therapeutics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. INFANTILE SPASMS THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2022 VS 2030
• FIGURE 3. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2022 VS 2030 (%)
• FIGURE 5. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
• FIGURE 6. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. INFANTILE SPASMS THERAPEUTICS MARKET DYNAMICS
• FIGURE 8. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. INFANTILE SPASMS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. INFANTILE SPASMS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. INFANTILE SPASMS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 5. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 8. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY PARENTAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 11. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 12. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 13. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 14. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 15. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 16. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 17. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 18. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 20. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 22. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 23. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 24. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 26. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 27. AUSTRALIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 28. AUSTRALIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. CHINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 30. CHINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 31. INDIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 32. INDIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. INDONESIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 34. INDONESIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. JAPAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 36. JAPAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. MALAYSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 38. MALAYSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. PHILIPPINES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 40. PHILIPPINES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. SINGAPORE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 42. SINGAPORE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. SOUTH KOREA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 44. SOUTH KOREA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. TAIWAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 46. TAIWAN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. THAILAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 48. THAILAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. VIETNAM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 50. VIETNAM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 53. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 55. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 56. EGYPT INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 57. EGYPT INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. FINLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 59. FINLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 61. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 63. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. ISRAEL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 65. ISRAEL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 67. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 69. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. NIGERIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 71. NIGERIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. NORWAY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 73. NORWAY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. POLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 75. POLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. QATAR INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 77. QATAR INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 79. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 81. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 85. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. SWEDEN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 87. SWEDEN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 88. SWITZERLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 89. SWITZERLAND INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. TURKEY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 91. TURKEY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 93. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. INFANTILE SPASMS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 97. INFANTILE SPASMS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 98. INFANTILE SPASMS THERAPEUTICS MARKET LICENSE & PRICING